Dear Colleagues,
The editorial team would like to congratulate the winners of the Cancers 2020 Best Paper Award, who were chosen by a selection committee chaired by the Editor-in-Chief, Prof. Dr. Samuel C. Mok. Following a review process by the Award Evaluation Committee, four winners were selected.
Article:
Economic Evaluation of Population-Based BRCA1/BRCA2 Mutation Testing across Multiple Countries and Health Systems
By Ranjit Manchanda, Li Sun, Shreeya Patel, Olivia Evans, Janneke Wilschut, Ana Carolina De Freitas Lopes, Faiza Gaba, Adam Brentnall, Stephen Duffy, Bin Cui, Patricia Coelho De Soarez, Zakir Husain, John Hopper, Zia Sadique, Asima Mukhopadhyay, Li Yang, Johannes Berkhof and Rosa Legood
Cancers 2020, 12(7), 1929; doi: 10.3390/cancers12071929
Single-Cell Transcriptomic Analysis of Tumor-Derived Fibroblasts and Normal Tissue-Resident Fibroblasts Reveals Fibroblast Heterogeneity in Breast Cancer
By Aimy Sebastian, Nicholas R. Hum, Kelly A. Martin, Sean F. Gilmore, Ivana Peran, Stephen W. Byers, Elizabeth K. Wheeler, Matthew A. Coleman and Gabriela G. Loots
Cancers 2020, 12(5), 1307; doi: 10.3390/cancers12051307
Review:
Ferroptosis in Cancer Cell Biology
By Christina M. Bebber, Fabienne Müller, Laura Prieto Clemente, Josephine Weber and Silvia von Karstedt
Cancers 2020, 12(1), 164; doi: 10.3390/cancers12010164
Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence
By Raju K. Vaddepally, Prakash Kharel, Ramesh Pandey, Rohan Garje and Abhinav B. Chandra
Cancers 2020, 12(3), 738; doi: 10.3390/cancers12030738
Each winner (corresponding author) will receive CHF 500, a chance to publish a paper free of charge in Cancers in 2022 after the normal peer-review procedure, and an electronic certificate.
Please join us in congratulating the winners of the Cancers 2020 Best Paper Award. We would also like to take this opportunity to thank all of our authors for your continued support of Cancers.
Kind regards,
Cancers Editorial Office